Impact of Pulmonary Function Measurements on Long-Term Survival After Lobectomy for Stage I Non-Small Cell Lung Cancer

Annals of Thoracic Surgery

Volumn 100, Issue 1, 2015, Pages 271-276

  Berry, Mark F ^a,b   Jeffrey Yang, Chi Fu ^a   Hartwig, Matthew G ^a   Tong, Betty C ^a   Harpole, David H ^a   D'Amico, Thomas A ^a   Onaitis, Mark W ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON MONOXIDE;

AGED; CANCER LOCALIZATION; CANCER PATIENT; CANCER SIZE; CANCER SURGERY; CANCER SURVIVAL; CEREBROVASCULAR DISEASE; COMORBIDITY; CONFERENCE PAPER; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; HUMAN; HYPERTENSION; INDUCTION CHEMOTHERAPY; KIDNEY FAILURE; LENGTH OF STAY; LOBECTOMY; LONG TERM SURVIVAL; LUNG DIFFUSION CAPACITY; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; NON SMALL CELL LUNG CANCER; OVERALL SURVIVAL; PERIOPERATIVE PERIOD; PREDICTION; PRIORITY JOURNAL; ROBOT ASSISTED SURGERY; SURGICAL MORTALITY; THORACOTOMY; VIDEO ASSISTED THORACOSCOPIC SURGERY; CANCER STAGING; CARCINOMA, NON-SMALL-CELL LUNG; LUNG NEOPLASMS; LUNG RESECTION; MORTALITY; PATHOLOGY; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROCEDURES; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL RATE; TIME;

AGED; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LUNG NEOPLASMS; MALE; NEOPLASM STAGING; PNEUMONECTOMY; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PULMONARY DIFFUSING CAPACITY; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS;

EID: 84933675490     PISSN: 00034975     EISSN: 15526259     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2015.02.076     Document Type: Conference Paper

References (35)

1. D.S. Ettinger, W. Akerley, and H. Borghaei Non-small cell lung cancer clinical practice guidelines in oncology J Natl Compr Canc Netw 11 2013 645 653
2. R.J. Ginsberg, and L.V. Rubinstein Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group Ann Thorac Surg 60 1995 615 623
3. G. Myrdal, G. Gustafsson, M. Lambe, L.G. Horte, and E. Stahle Outcome after lung cancer surgery. Factors predicting early mortality and major morbidity Eur J Cardiothorac Surg 20 2001 694 699
4. R.L. Patel, E.R. Townsend, and S.W. Fountain Elective pneumonectomy: factors associated with morbidity and operative mortality Ann Thorac Surg 54 1992 84 88
5. A. Bernard, C. Deschamps, and M.S. Allen Pneumonectomy for malignant disease: factors affecting early morbidity and mortality J Thorac Cardiovasc Surg 121 2001 1076 1082
6. R. Wahi, M.J. McMurtrey, and L.F. DeCaro Determinants of perioperative morbidity and mortality after pneumonectomy Ann Thorac Surg 48 1989 33 37
7. D.J. Kearney, T.H. Lee, J.J. Reilly, M.M. DeCamp, and D.J. Sugarbaker Assessment of operative risk in patients undergoing lung resection. Importance of predicted pulmonary function Chest 105 1994 753 759
8. R.J. Pierce, J.M. Copland, K. Sharpe, and C.E. Barter Preoperative risk evaluation for lung cancer resection: predicted postoperative product as a predictor of surgical mortality Am J Respir Crit Care Med 150 1994 947 955
9. J. Wang, J. Olak, R.E. Ultmann, and M.K. Ferguson Assessment of pulmonary complications after lung resection Ann Thorac Surg 67 1999 1444 1447
10. T. Yano, H. Yokoyama, Y. Fukuyama, E. Takai, K. Mizutani, and Y. Ichinose The current status of postoperative complications and risk factors after a pulmonary resection for primary lung cancer. A multivariate analysis Eur J Cardiothorac Surg 11 1997 445 449
11. M.K. Ferguson, L.B. Reeder, and R. Mick Optimizing selection of patients for major lung resection J Thorac Cardiovasc Surg 109 1995 275 281
12. J. Markos, B.P. Mullan, and D.R. Hillman Preoperative assessment as a predictor of mortality and morbidity after lung resection Am Rev Respir Dis 139 1989 902 910
13. M.K. Ferguson, L. Little, and L. Rizzo Diffusing capacity predicts morbidity and mortality after pulmonary resection J Thorac Cardiovasc Surg 96 1988 894 900
14. M. Bousamra, K.W. Presberg, and J.H. Chammas Early and late morbidity in patients undergoing pulmonary resection with low diffusion capacity Ann Thorac Surg 62 1996 968 974
15. M.K. Ferguson Preoperative assessment of pulmonary risk Chest 115 Suppl 1999 58 63
16. M.K. Ferguson, J. Siddique, and T. Karrison Modeling major lung resection outcomes using classification trees and multiple imputation techniques Eur J Cardiothorac Surg 34 2008 1085 1089
17. M.K. Ferguson, and A.E. Durkin A comparison of three scoring systems for predicting complications after major lung resection Eur J Cardiothorac Surg 23 2003 35 42
18. J. Wang, J. Olak, and M.K. Ferguson Diffusing capacity predicts operative mortality but not long-term survival after resection for lung cancer J Thorac Cardiovasc Surg 117 1999 581 586
19. M.K. Ferguson, and W.T. Vigneswaran Diffusing capacity predicts morbidity after lung resection in patients without obstructive lung disease Ann Thorac Surg 85 2008 1158 1164
20. A. Brunelli, M.A. Refai, M. Salati, A. Sabbatini, N.J. Morgan-Hughes, and G. Rocco Carbon monoxide lung diffusion capacity improves risk stratification in patients without airflow limitation: evidence for systematic measurement before lung resection Eur J Cardiothorac Surg 29 2006 567 570
21. C.D. Wright, H.A. Gaissert, J.D. Grab, S.M. O'Brien, E.D. Peterson, and M.S. Allen Predictors of prolonged length of stay after lobectomy for lung cancer: a Society of Thoracic Surgeons general thoracic surgery database risk-adjustment model Ann Thorac Surg 85 2008 1857 1865
22. M.D. Taylor, D.J. LaPar, J.M. Isbell, B.D. Kozower, C.L. Lau, and D.R. Jones Marginal pulmonary function should not preclude lobectomy in selected patients with non-small cell lung cancer J Thorac Cardiovasc Surg 147 2014 738 744
23. D.P. Ceppa, A.S. Kosinski, and M.F. Berry Thoracoscopic lobectomy has increasing benefit in patients with poor pulmonary function: a Society of Thoracic Surgeons Database analysis Ann Surg 256 2012 487 493
24. M.F. Berry, N.R. Villamizar-Ortiz, and B.C. Tong Pulmonary function tests do not predict pulmonary complications after thoracoscopic lobectomy Ann Thorac Surg 89 2010 1044 1051
25. B.M. Burt, A.S. Kosinski, J.B. Shrager, M.W. Onaitis, and T. Weigel Thoracoscopic lobectomy is associated with acceptable morbidity and mortality in patients with predicted postoperative forced expiratory volume in 1 second or diffusing capacity for carbon monoxide less than 40% of normal J Thorac Cardiovasc Surg 148 2014 19 29
26. P. Goldstraw, J. Crowley, and K. Chansky The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours J Thorac Oncol 2 2007 706 714
27. M.K. Ferguson, J.J. Dignam, J. Siddique, W.T. Vigneswaran, and A.D. Celauro Diffusing capacity predicts long-term survival after lung resection for cancer Eur J Cardiothoracic Surg 41 2012 e81 e86
28. M.K. Ferguson, S. Watson, E. Johnson, and W.T. Vigneswaran Predicted postoperative lung function is associated with all-cause long-term mortality after major lung resection for cancer Eur J Cardiothorac Surg 45 2014 660 664
29. A. Brunelli, C. Pompili, and M. Salati Preoperative maximum oxygen consumption is associated with prognosis after pulmonary resection in stage I non-small cell lung cancer Ann Thorac Surg 98 2014 238 242
30. C. Pompili, M. Salati, and M. Refai Preoperative quality of life predicts survival following pulmonary resection in stage I non-small cell lung cancer Eur J Cardiothoracic Surg 43 2013 905 910
31. T. Crabtree, V. Puri, and R. Timmerman Treatment of stage I lung cancer in high-risk and inoperable patients: comparison of prospective clinical trials using stereotactic body radiotherapy (RTOG 0236), sublobar resection (ACOSOG Z4032), and radiofrequency ablation (ACOSOG Z4033) J Thorac Cardiovasc Surg 145 2013 692 699
32. R. Timmerman, R. Paulus, and J. Galvin Stereotactic body radiation therapy for inoperable early stage lung cancer JAMA 303 2010 1070 1076
33. National Cancer Institute at the National Institutes of Health clinical trials home page. Available at: http://www.cancer.gov/clinicaltrials. Accessed June 27, 2014.
34. M.D. Taylor, A.S. Nagji, and C.M. Bhamidipati Tumor recurrence after complete resection for non-small cell lung cancer Ann Thorac Surg 93 2012 1813 1820
35. H.C. Fernando, R.S. Santos, and J.R. Benfield Lobar and sublobar resection with and without brachytherapy for small stage IA non-small cell lung cancer J Thorac Cardiovasc Surg 129 2005 261 267